Anhedonia  >>  aticaprant (JNJ-67953964)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
aticaprant (JNJ-67953964) / J&J
FASTMAS_Kor2, NCT02218736: Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a

Completed
2a
163
US
CERC-501, Kappa Opioid Receptor Antagonist; LY2456302, placebo
Duke University, Yale University, Baylor College of Medicine, Indiana University, Icahn School of Medicine at Mount Sinai, Case Western Reserve University
ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)
11/17
12/17

Download Options